Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.01 USD | +2.10% | +11.00% | +75.49% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 438M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -76M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M | Net cash position 2025 * | 501M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.31
x | P/E ratio 2025 * |
-9.48
x | Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.22% |
Latest transcript on Neurogene Inc.
1 day | +2.10% | ||
1 week | +11.00% | ||
Current month | -1.36% | ||
1 month | +11.54% | ||
3 months | +14.13% | ||
Current year | +75.49% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 34.01 | +2.10% | 96,435 |
24-05-17 | 33.31 | -1.22% | 49,599 |
24-05-16 | 33.72 | +0.39% | 57,033 |
24-05-15 | 33.59 | +6.47% | 51,187 |
24-05-14 | 31.55 | +2.97% | 82,957 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.49% | 438M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+49.62% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- NGNE Stock